The global Western Blotting Market is estimated to attain a valuation of USD 980.1 million in 2023 and is anticipated to reach USD 1753.4 million by 2033, trailing a CAGR of 6% during the forecast period.
The growing prevalence of Lyme and Human Immuno Deficiency (HIV) diseases in the region is a significant driver for market growth. Increased research activities, research and development investments by pharmaceutical and biotechnology companies, and advancements in the proteomics sector further contribute to market growth. The rise in industry-academic research collaborations and the growing demand for personalized medicine also play a role in influencing the market.
Get a PDF Sample with Latest Market Insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1050
The global western blotting market is expected to be driven by the increasing prevalence of HIV during the forecast period, as western blotting is predominantly utilized for HIV detection. For example, in January 2022, data from UNAIDS, a Joint United Nations Programme involved in Human Immuno Deficiency epidemiology data collection, indicated that 1.5 million people were newly infected with HIV in 2021.
The market is positively influenced by factors such as rapid urbanization, advancements in healthcare infrastructure, and increased healthcare expenditure. The introduction of new products and automation in western blotting instruments create profitable opportunities for market players in the forecast period.
In comparison to other immunosorbent assays (ISAs) like Enzyme-Linked Immunosorbent Assay (ELISA), Western blotting or immunoblotting offers numerous advantages. Western blotting is a more advanced technique as it allows for separation of protein mixtures based on charge, size, and/or conformation. Unlike ELISA, which can only detect one protein, western blotting allows for the detection of multiple targets using the method of stripping. The size of the target protein can be assessed through gel electrophoresis, which helps in separating proteins into bands. This adoption of western blotting technique is expected to augment growth in the market.
Key Takeaways:
- North America is expected to dominate the market while growing with a CAGR of 5.8% during the forecast period.
- The market in India is projected to witness a CAGR of 6.1% during the forecast period.
- The market in China is expected to grow at a 7.4% CAGR during the forecast period.
- By product type, reagent kits are projected to lead the segment and are estimated to grow with a CAGR of 7.2% during the forecast period.
- By application, scientific research segment is expected to lead the market. It is expected to grow with a CAGR of 7% throughout the forecast period.
Rising prevalence of HIV and increasing healthcare expenditure are expected to drive market growth over the forecast period-Comments an FMI Analyst
Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-1050
Competitive Landscape:
The western blotting market is extremely competitive and consists of various key industry players. These players are heavily investing in the western blotting market.
The key industry players are Thermo Fisher Scientific, Inc., GE Healthcare, Hofmann-La Roche Ltd., Danaher Corporation (Lumigen, Inc.), EMD Millipore Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., LI-COR, Inc., Bio-Techne Corporation (ProteinSimple Inc.), Advansta, Inc.
Some recent developments in the market are:
Key industry players leverage organic growth strategies like acquisition, mergers, partnerships, and collaboration to enhance their product portfolio. This is expected to fuel the global western blotting market.
- In January 2022, Bio-Techne Corporation made an announcement regarding the release of Stellar NIR/IRTM Detection Modules for Jess by ProteinSimple, a Bio-Techne brand. These Stellar fluorescent modules offer the capability to detect low abundant proteins while simultaneously enabling multiplexing of multiple analytes in a single detection lane.
- In November 2021, Aviva Systems Biology, a prominent provider of antibodies, immunoassay kits, and recombinant proteins for life science research, announced its participation in the YCharOS Industry Advisory Committee (IAC).
- Bio-Rad Laboratories, Inc., a leading provider of life science research and clinical diagnostic products, launched the Bio-Rad Western Blotting Learning Center in January 2021.
For more Report Customization, connect with us at@ https://www.futuremarketinsights.com/customization-available/rep-gb-1050
Key segments profiled in the western blotting market Industry survey
By Product Type:
- Electrophoresis Blotting Systems
- Automated Dry Blotting Systems
- Semi-Dry Blotting Systems
- Traditional Wet Transfer Blotting Systems
- Reagent Kits
- Chromogenic Reagent Kits
- Chemiluminescent Reagent Kits
- Horseradish Peroxidase (HRP) Substrate
- Alkaline Phosphatase (AP) Substrate
- Fluorescent Reagents
- Antibodies
- Primary Antibody
- Secondary Antibody
- Buffer Kits
By Application:
- Research
- Diagnostics
- Agricultural
- Food & Beverages
- Other Applications
End User:
- Diagnostic Laboratories
- Research Institutions
- Pharmaceutical & Biotechnology Companies
Use promo code >> FMITODAY to get flat 20% discount
Region:
- North America
- Latin America
- Europe
- Middle East and Africa (MEA)
- East Asia
- South Asia
- Oceania
More Valuable Insights Available:
Future Market Insights offers an unbiased analysis of the global western blotting market, providing historical data for 2017 to 2022 and forecast statistics from 2023 to 2033.
To understand opportunities in the western blotting market, the market is segmented on the basis of product type, application type, by end-user, by region.
